Skip to main content
. 2019 Aug 3;33(4):670–677. doi: 10.5713/ajas.19.0463

Figure 3.

Figure 3

Plasma concentration-time profiles of LMT-28 after intravenous (circle) and oral (triangle) administration at doses of 5 mg/kg in male BALB/c mice (mean±standard deviation, n = 4).